Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- MNDY +23.2%, BW +12.1%, CEVA +8.2%, LQDA +7.9%, IX +6.7%, RDNT +6.5%, MLTX +5.5%, SDRL +5.2%, KSPI +2.9%
Other news:
- BZH +21.5% (Dream Finders Homes (DFH) confirms it will acquire Beazer Homes (BZH) for $25.75/share in cash)
- DGXX +10.8% (announces the upsizing by US$100 mln of the previously announced "at-the-market" equity offering program)
- DRTS +10.3% (announced interim data from its U.S. trial of Alpha DaRT for patients with recurrent glioblastoma trial; Conference call with principal investigator to be held today, Monday, May 11)
- EEX +9.6% (Apollo Funds (APO) to acquire Emerald and Questex with the intention to combine the businesses in an all-cash transaction)
- INBX +5.7% (to provide clinical update on INBRX-106 HexAgon study in first line HNSCC)
- DFH +5% (Dream Finders Homes (DFH) confirms it will acquire Beazer Homes (BZH) for $25.75/share in cash)
- LITE +4.8% (to join the Nasdaq-100 Index beginning May 18, 2026)
- ARGX +2.3% (FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG)
- PBI +2.2% (Hestia Capital Mgmt distributes 1.5 mln shares to limited partners; CEO Kurt Wolf intends to retain large personal stake in PBI)
- SAIL +2% (detected unauthorized access to a subset of its GitHub repositories)
- ALVO +1.8% (reports FDA completed Reykjavik facility inspection)
- REAL +1.4% (files mixed securities shelf offering)
- IVVD +1.3% (announces that a preprint of original research regarding COVID monoclonal antibody and vaccine systemic reactogenicity is now available on MedRxiv) INDI +1.2% (announced the signing of a definitive agreement to acquire the fabless CMOS image sensor group from AMS OSRAM AG for a total consideration of EUR 40 mln)